Author

Tomer Lauterman

Observed name: T. Lauterman

Observed institution: Veracyte (United States)

OpenAlex ID: A5035197225

Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma

2024 · Iver Nordentoft, Sia Viborg Lindskrog, et al. · European Urology · 57

Detection of circulating tumor DNA by tumor-informed whole-genome sequencing enables prediction of recurrence in stage III colorectal cancer patients

2024 · Amanda Frydendahl, Jesper Nors, et al. · European Journal of Cancer · 20

Abstract 5114: Ultra-sensitive detection of minimal residual disease (MRD) through whole genome sequencing (WGS) using an AI-based error suppression model in resected early-stage non-small cell lung cancer (NSCLC)

2022 · Aaron C. Tan, Stephanie P. Saw, et al. · Cancer Research · 7

Ultrasensitive detection and monitoring of central nervous system tumors from plasma using personalized whole-genome ctDNA profiling.

2023 · Ivy Tran, Kristyn Galbraith, et al. · Journal of Clinical Oncology · 3

Accuracy of genome-wide mutational analysis for tumor-informed ctDNA-guided MRD monitoring in bladder cancer.

2023 · Iver Nordentoft, Sia Viborg Lindskrog, et al. · Journal of Clinical Oncology · 3

Abstract 3770: Comparison of ctDNA detection methods for monitoring minimal residual disease in patients with bladder cancer: Insights from the TOMBOLA Trial

2025 · Iver Nordentoft, Karin Birkenkamp-Demtröder, et al. · Cancer Research · 1

Abstract 6689: Whole genome cell-free tumor DNA mutational signatures from blood for early detection of recurrence of low stage lung adenocarcinoma

2023 · Ivy Tran, Alejandro Vargas, et al. · Cancer Research · 1

Abstract 1036: Detection of circulating tumor DNA by whole genome sequencing enables prediction of recurrence in stage III colorectal cancer patients with great inter-lab reproducibility

2023 · Amanda Frydendahl, Jesper Nors, et al. · Cancer Research · 1

Abstract 2305: Ultra-sensitive detection of circulating tumor DNA by whole-genome sequencing of blood samples from locally advanced rectal cancer patients receiving neoadjuvant therapy and enrolled in watch-and-wait strategies for organ preservation

2023 · Francisco Sanchez-Vega, Chin-Tung Chen, et al. · Cancer Research · 1

Abstract 1959: Sensitive detection of circulating tumor DNA by whole genome sequencing: Validation of MRDetect using serial blood samples from stage III colorectal cancer patients

2022 · Amanda Frydendahl, Thomas Reinert, et al. · Cancer Research · 1

BIOM-23. A PILOT STUDY OF WHOLE GENOME SEQUENCING (WGS) OF PLASMA CELL-FREE DNA (cfDNA) FOR ULTRASENSITIVE DETECTION OF TUMOR DNA IN PATIENTS WITH GLIOBLASTOMA (GBM)

2021 · Stephen J Bagley, Jacob Till, et al. · Neuro-Oncology · 1

Predicting Recurrence of Stage IA Lung Adenocarcinoma Using Circulating Tumor Cell–Free DNA Whole-Genome Mutational Signatures

2026 · Matija Snuderl, James Smadbeck, et al. · Journal of Molecular Diagnostics

Abstract 540: Genome-wide circulating tumor DNA for monitoring treatment response and metastatic relapse in bladder cancer

2022 · Iver Nordentoft, Karin Birkenkamp-Demtröder, et al. · Cancer Research

Abstract 3401: Whole genome cell-free tumor DNA mutational signatures for noninvasive monitoring of pediatric brain cancers

2022 · Ivy Tran, Kristyn Galbraith, et al. · Cancer Research

Lab validation of an ultrasensitive ctDNA pan-cancer MRD assay using whole-genome sequencing.

2022 · Ravi Kandasamy, Eric White, et al. · Journal of Clinical Oncology

Genome-wide circulating tumor DNA monitoring for bladder cancer treatment management and organ preservation.

2021 · Iver Nordentoft, Emil Christensen, et al. · Journal of Clinical Oncology

Works count: 17

Citation count: 96

H-index: 3

I10-index: 2